PCI Biotech Holding
Less than 1K followers
PCIB
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
PCI Biotech Holding is a biopharmaceutical group, where most of the operations are conducted within the subsidiary PCI Biotech. The Group currently conducts operations in the development of therapeutic products based on the proprietary PCI technology. The solutions are intended for use in the treatment of cancer patients. PCI Biotech was originally founded in 2000 as a subsidiary of Photocure and is headquartered in Oslo.
Read moreMarket cap
-
Turnover
-
Revenue
6.74M
EBIT %
-266.47 %
P/E
-
Dividend yield-%
-
Financial calendar
22.5
2025
General meeting '25
29.8
2025
Interim report Q2'25
ShowingAll content types
PCI Biotech: Invitation to preliminary full-year 2024 results presentation
PCI Biotech: Employee share option scheme in connection with promotion of new CSO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools